FILING ANALYSIS · THURSDAY, NOVEMBER 5
COLLEGIUM PHARMACEUTICAL, INC COLL — 8-K: Results of Operations and Financial Condition
positive
Collegium Pharmaceutical reported record quarterly net revenues of $216.3 million, up 3% year-over-year, and reaffirmed its 2026 guidance, with the ADHD franchise contributing over 36% of total revenue. The company also announced a $50 million accelerated share repurchase program.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →